Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

6 trials match this view; 8 reported facilities; 8 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 384 across 6 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20231
20243
20262

Current indexed registry status

Recruiting2
Active, not recruiting2
Not yet recruiting2

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

6 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer

NCT06001749

Opioid-Related Disorders · Pain Management · Pain Management and Care · Advanced Cancer · Advanced Cancers
Yvan Beaussant, MD, MSci

PHASE2

Active, not recruiting

Registry updated 2026-10-27

15

ESTIMATED

2024-09-23
2026-10-01
2026-12-31
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial

NCT06416085

Advanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer
University Health Network, Toronto

PHASE2

Active, not recruiting

Registry updated 2026-06-22

15

ESTIMATED

2024-06-06
2026-12-15
2026-12-15
TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

NCT06200155

Depression, Anxiety · Psilocybin-Assisted Psychotherapy · Advanced Cancer
M.D. Anderson Cancer Center

PHASE2

Recruiting

Registry updated 2026-11-03

48

ESTIMATED

2024-04-16
2026-12-31
2026-12-31
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer

NCT05398484

Advanced Cancer
NYU Langone Health

PHASE2, PHASE3

Recruiting

Registry updated 2026-10-14

200

ESTIMATED

2023-05-24
2027-01-01
2027-01-01
High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite Trial

NCT07791901

Advanced Cancer · Demoralization · Existential Distress · Psychological Distress
University of Calgary

PHASE2

Not yet recruiting

Registry updated 2026-09-02

60

ESTIMATED

2026-10-30
2027-12-20
2027-12-31
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial

NCT07820033

Advanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer
University Health Network, Toronto

PHASE2

Not yet recruiting

Registry updated 2026-10-15

46

ESTIMATED

2026-09-14
2028-12-30
2029-07-30

Reported research facilities

Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada · Coordinates available
Princess Margaret Cancer CentreToronto, Ontario, Canada · Coordinates available
Providence Care HospitalKingston, Ontario, Canada · Coordinates available
University Health NetworkToronto, Ontario, Canada · Coordinates available
Dana-Farber Cancer InstituteBoston, Massachusetts, United States · Coordinates available
MD Anderson Cancer CenterHouston, Texas, United States · Coordinates available
NYU Langone HealthNew York, New York, United States · Coordinates available
University of Colorado Anschutz Medical campus (CU AMC)Aurora, Colorado, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.